XXF Announces Board Reshuffle: Executive Exits, Prof. Wang Joins as Independent Director and Committee Chair

Bulletin Express
10/15

On 15 October 2026, XXF Group Holdings Limited (XXF, HKEX: 02473) unveiled a series of governance changes that will reshape its board and key committees over the next month.

Effective 15 October 2026, Executive Director Ms. Zhang Jinghua resigned from the board, the Nomination Committee, and her role as Authorised Representative. Non-Executive Director Mr. Liu Wei also stepped down. Both cited personal commitments and confirmed no disagreements with the board.

On the same date, Prof. Wang Lihong, aged 45, was appointed as an Independent Non-Executive Director and immediately joined the Nomination Committee. Prof. Wang holds a Ph.D. in Finance from KU Leuven and serves as a professor at Xiamen University’s Institute for Financial & Accounting Studies. Her three-year term carries annual remuneration of RMB0.12 million.

Further succession moves take effect on 9 November 2026. Incumbent Independent Non-Executive Director Mr. Wu Fei will retire, relinquishing roles on the Nomination and Audit Committees and as chairman of the Remuneration Committee. Prof. Wang will assume Mr. Wu’s positions on both committees, becoming chairman of the Remuneration Committee and a member of the Audit Committee.

To fill the Authorised Representative vacancy created by Ms. Zhang’s departure, Company Secretary Ms. Mak Po Man Cherie has been appointed to the role from 15 October 2026.

Chairman and CEO Mr. Huang Wei expressed appreciation for the outgoing directors’ contributions and welcomed Prof. Wang to the board. Following these changes, the board comprises two Executive Directors—Mr. Huang Wei and Mr. Ye Fuwei—and four Independent Non-Executive Directors: Mr. Wu Fei (until 9 November 2026), Mr. Fung Che Wai Anthony, Mr. Chen Shuo, and Prof. Wang Lihong.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10